Theradiag Logo

Theradiag

Develops and markets in-vitro diagnostic solutions for biotherapy monitoring.

ALTER | PA

Overview

Corporate Details

ISIN(s):
FR00140069U4 (+1 more)
LEI:
969500CDG241WHIFL611
Country:
France
Address:
14 RUE AMBROISE CROIZAT, 77183 CROISSY-BEAUBOURG

Description

Theradiag is a company that develops, manufactures, and markets in-vitro diagnostic (IVD) solutions, with a primary focus on theranostics. The company specializes in creating tools for monitoring biotherapies, which are treatments using substances derived from living organisms. Its core product line, Lisa-Tracker, is a range of kits designed to help clinicians measure the efficacy of biotherapies, particularly for patients with autoimmune diseases. This allows for the personalization of treatment and improved patient outcomes. In addition to its focus on biotherapy monitoring, Theradiag also maintains its activities in developing and distributing diagnostic tests for autoimmunity and oncogenetics. The company leverages its extensive experience to provide innovative diagnostic tools for clinicians and patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-10-17 17:45
Rapport financier semestriel
French 9.4 MB
2017-10-16 08:00
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 309.4 KB
2017-10-16 08:00
Communicated under the obligation to provide permanent information / Other comm…
English 306.9 KB
2017-10-02 18:00
Information relative au nombre total de droits de vote et d'actions composant l…
French 470.7 KB
2017-09-01 20:37
Information relative au nombre total de droits de vote et d'actions composant l…
French 289.3 KB
2017-07-07 17:45
Information relative au nombre total de droits de vote et d'actions composant l…
French 288.9 KB
2017-07-06 18:00
Rachat d'actions / Contrat de liquidité Information relative au contrat de liqu…
French 287.4 KB
2017-06-14 08:00
Communicated under the obligation to provide permanent information / Other comm…
English 478.7 KB
2017-06-14 08:00
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 614.8 KB
2017-06-06 18:30
Information relative au nombre total de droits de vote et d'actions composant l…
French 291.0 KB
2017-05-12 08:00
Communications during bidding periods / Other releases
English 614.1 KB
2017-05-12 08:00
Communiqués en période d’offre / Autres communiqués
French 391.3 KB
2017-05-11 18:15
Communicated under the obligation to provide permanent information / Other comm…
English 405.2 KB
2017-05-11 18:15
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 385.8 KB
2017-05-04 17:45
Information relative au nombre total de droits de vote et d'actions composant l…
French 290.9 KB

Automate Your Workflow. Get a real-time feed of all Theradiag filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Theradiag

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Theradiag via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.